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ABSTRACT 
Objective: Red ginseng has been used as traditional medicines and functional foods in the world, because of its health benefits. The aim of this study 
was to elucidate the anti-inflammatory effect and mechanism of pectinase-modified red ginseng (GS-E3D) with a cellular model of 
lipopolysaccharide (LPS)-stimulated RAW264.7 cells.  
Methods: To study the anti-inflammatory effect of GS-E3D, the key inflammation mediators such as nitric oxide (NO),prostaglandin E2 (PGE2
Results: GS-E3D potently inhibited TNF-α and IL-6 and also diminished NO over-production, which was accompanied by the down-regulation of 
iNOS expression. GS-E3D effectively suppressed LPS-induced NF-κB activation through inhibiting the hyper-phosphorylation and degradation of 
IκB-α and phosphorylation of p38, ERK1/2 and JNK in MAPK signaling pathway. 
), 
inducible nitric oxide synthase (iNOS), Cyclooxygenase-2 (COX-2), tumor necrosis factor (TNF-α), and interleukin (IL)-6 production as well as on 
nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs) activation, were measured by using the enzyme linked 
immunosorbent assay (ELISA)and Western blotting. 
Conclusion: GS-E3D has a potential to be as an anti-inflammatory agent for functional food or cosmetic materials targeting on the NF-κB p65 and 
MAPKs signaling pathways. 
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INTRODUCTION 
Inflammatory response is mediated by oxidative stress occurring in the 
body which increase the gene expression of a particular cell to cause cell 
death, as well as responsible for the initiation of degenerative diseases or 
became attenuating the inflammatory response [1]. Macrophages are 
immune cells distributed to all tissues which are responsible for innate 
immune response, as the white blood cells have played a key role in the 
body's immune system. Macrophagesin inflammations are activated by 
bacterial lipopolysaccharide (LPS) of cell wall components of Gram-
negative bacteria [2]. Activated macrophages produce inflammatory 
mediators such as nitric oxide (NO), prostaglandin E2 (PGE2
Ginseng is used as a popular herbal medicine and functional food in the 
world andits pharmacological constituents, ginsenosides, exhibit various 
biological effects, including anti-inflammatory and antitumor activity [5-
7]. Ginsenosides are about 40 types have been known up to now, but the 
main components of ginseng is six numbers, namely, ginsenoside Rg1, Re, 
Rb1, Rb2, Rc and Rd. Ginsenoside Rb1, Rb2 and R care transformed into 
ginsenoside Rd, F2 and compound K by microbial enzyme such as 
glycosidase [8]. Ginsenoside Rd exhibits potent anti-inflammatory, anti-
obesity, and anti-ischemic effects [9-12]. In this study, we prepared 
commercial pectin lyase-modified red ginseng extracts (GS-E3D) 
enhanced with ginsenoside Rd for development of functional food or 
cosmetic materials and observed its anti-inflammatory effects and 
mechanism on LPS-stimulated RAW264.7 cells.  
), inducible 
nitric oxide synthase (iNOS), Cyclooxigenase-2 (COX-2), tumor necrosis 
factor (TNF-α),and interleukin (IL)-6 [3]. LPS stimulate a serial of signal 
transduction events which lead to the activation of pro-inflammatory 
cytokine such as nuclear factor kappaB (NF-κB) and mitogen-activated 
protein kinases (MAPKs) such as ERK, JNK and p38 [4]. 
MATERIALS AND METHODS 
Plant material and preparation of GS-E3D 
The Panax (P.) ginseng used in this experiment was 4-year-old dried 
ginseng purchased from a local market (Wooshin Industrial Co., Ltd., 
Geumsan, Korea) and was deposited in the International Ginseng and 
Herb Research Institute (No. GS201104). GS-E3D was prepared 
according to early our report [13]. Briefly, red ginseng extract adjusted 
to 6 Brix were incubated with 10% pectin lyase (EC 4.2.2.10, 
Novozyme, #33095, Denmark) at 50 °C for 5 d in a shaking incubator 
(150 rpm). To terminate the reaction, processed extracts were heated 
at 95 °C for 10 min, and then freeze-dried for further experiment. The 
dried GS-E3D consisted of 120.2 mg/g crude saponin containing the 
following ginsenosides: 5.9 mg/g Rg1, 12.6 mg/g Re, 4.7 mg/g Rf, 30.2 
mg/g Rb1, 14.0 mg/g Rc, 17.6 mg/gRb2, 2.5 mg/g Rb3, 27.7 mg/g Rd, 
1.3 mg/g 20(S)-Rg3, 1.4 mg/g 20(R)-Rg3, 0.8 mg/g Rk1, and 1.5 mg/g 
Rg5. 
Cell culture 
RAW264.7 cells, a mouse peritoneal macrophage line, was purchased 
from American Type Culture Collection (ATCC, Rockville, MD, USA) 
and maintained in a 5% CO2
Cell viability assay 
 atmosphere in Dulbecco’s modified 
Eagle’s medium (DMEM; Gibco-BRL, Grand Island, NY, USA) 
supplemented with 5% heat-inactivated fetal bovine serum (FBS), 100 
μg/ml streptomycin, and 100 U/ml penicillin (Gibco-BRL). The 
medium for RAW264.7 cells was routinely changed twice a day. 
RAW264.7 was passaged by trypsinization until they reached 
confluency level. 
To determine the effect of GS-E3D on cell viability, RAW264.7 cells 
were seeded on 96-well plates at a density of 5×104 cells/well. GS-E3D 
was added at serially indicated concentrations. Control group was 
treated with an equal amount of DMSO, which resulted in a final 
concentration of 0.3% DMSO in the medium. After the treatment of GS-
E3D at 24 h, 3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium 
bromide (MTT) solution was added and then the cells were further 
incubated for another4 h at 37 °C. After removing the medium, 100 μl 
of DMSO was added to the cells. The absorbance was measured by 
using anenzyme linked immunosorbent assay (ELISA) microplate 
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reader at 450 nm. The control group consisted of untreated cells was 
considered as 100% of viable cells. Results are expressed as 
percentage of viable cells when compared with control groups. 
Determination of NO and PGE2
Inhibitory effect of GS-E3D on NO production by murine macro phage 
like RAW264.7 cells was evaluated using a method modified from 
previously reported [14]. Briefly, the RAW264.7 cells (2×10
 production 
5 cells/well) 
in 10% FBS-DMEM without phenol red were seeded in a 6-well plate 
for 24 h at 37°C. Cells were washed with 1×PBS, replaced with fresh 
media, and then treated with the varying concentrations of the GS-E3D 
for 30 min. After 30 min, LPS (1 μg/ml) was treated for 24 h at 37°C. 
After 24 h of LPS treatment, 100 μl of the medium was transferred in 
to a 96 well plate and then an equal amount of Griess reagent (1% 
sulfanilamide and 0.1% N-1-(naphthyl) ethylenediamine-
dihydrochloride in 2.5% H3PO4) was added. The plate was incubated 
for additional 5 min at the room temperature and then the absorbance 
was measured at 540 nm using the ELISA microplate reader. The 
amount of NO was calculated using sodium nitrite standard curve. For 
the measurement of PGE2 production, 50 μl of the supernatant of 
cultured medium was collected, and PGE2 production was determined 
using PGE2
Determination of TNF-α release 
 ELISA monoclonal assay kit followed (Cayman Chemical, 
Ann Arbor, MI) with manufacturer’s instructions. 
RAW264.7 cells (2×105
SDS-PAGE and western blot 
cells/well) in 10% FBS-DMEM were seeded in a 
6-well plate for 24 h at 37°C. Cells were washed with 1×PBS, replaced 
with fresh media, and then treated with the varying concentrations of 
GS-E3D for 30 min. After 30 min, LPS (1 μg/ml) was treated for 24 h at 
37 °C. At 24 h after LPS treatment, 50 μl of the supernatant of cultured 
medium was collected, and TNF-α was determined using Human TNF-
α ELISA kit (R&D systems, Minneapolis, MN) following with 
manufacturer’s instructions. 
The cells were washed with 1 x phosphate-buffered saline (PBS), and 
lysed in NP-40 lysis buffer supplemented with protease and 
phosphatase inhibitor cocktail (Sigma Aldrich, St. Louis, MO, USA), and 
centrifuged at 15,000 x g at 4°C for 20 min. The supernatant containing 
protein concentration was determined by Bradford protein assay. 
Equal amount of proteins were subjected to SDS-PAGE and then 
transferred onto PVDF membrane. The membranes were blocked for 
non-specific binding with 5% non-fat dry milk in tris-buffered saline 
containing 0.05 % Tween 20 (TBS-T) for 1hat room temperature and 
then probed with the primary antibodies overnight at 4 °C, followed by 
incubation with horse radish peroxidase (HRP)-conjugated 
immunoglobulin G (IgG) for 1h at room temperature. Chemi-
luminescence was detected with ECL Western blotting substrate (GE 
Health care, Pittsburgh, PA, USA) and visualized in polaroid film. 
RESULTS AND DISCUSSION  
In vitro cytotoxicity of GS-E3D against RAW264.7 cells 
The cell viability was determined by MTT assay. RAW264.7 cells were 
treated with various concentrations of GS-E3D for 24 h. As shown in 
fig. 1A, extracts did not exhibit cytotoxicity at the range of 25-200 
μg/ml against RAW264.7 cells. This dose-range was used for the 
treatment of GS-E3D for further experiments.  
GS-E3D inhibits the production of NO and PGE2
NO is generated from L-arginine by nitric oxide synthase. iNOS is 
strongly induced by the bacterial toxins and body’s inflammatory 
cytokines [15]. A significant increase of NO by iNOS under pathological 
conditions, along with other inflammatory mediators causing tissue 
damage, is a major mediator of inflammatory damage [16,17].  
 by suppressing 
iNOS and COX-2 expression in LPS-stimulated RAW264.7 cells  
Therefore, compounds which are capable of inhibiting the production 
of NO by inhibiting iNOS expression or activity may be used as an anti-
inflammatory substance. Pro-inflammatory macrophage cytokine 
activated the cyclooxygenase-2 (COX-2) which plays an important role 
in the inflammatory phase by increasing the PGE2 
To determine whether GS-E3D inhibit the production of NO induced by 
LPS which plays a central role in the inflammatory response, 
RAW264.7 cells were pretreated with the GS-E3D for 30 min and then 
stimulated with LPS (1 μg/ml). After stimulation for 24 h, the cell 
medium was harvested, and the production of NO was measured using 
the Griess assay. RAW264.7 cells unstimulated by LPS and treated with 
GS-E3D alone without LPS secreted basal level of NO, while the 
stimulation of LPS without GS-E3D resulted in an increased level of NO 
production. GS-E3D significantly inhibited the production of LPS-
induced NO in a concentration-dependent manner. 
subsequently 
produced inflammatory reaction causes an inflammatory response.  
 
Fig. 1: Cytotoxicity (A) and inhibitory effect of GS-E3D on NO (B) 
and PGE2 (C) production in LPS-stimulated RAW 264.7cells. The 
cells were pretreated with the varying concentrations of GS-E3D 
and then treated with LPS (1 μg/ml). Data are expressed as the 
mean±SEM. (n=5). ### p<0.001 compared to control group. *** 
p<0.001 compared to LPS group (ANOVA followed by Tukey's test) 
 
Fig. 2: Inhibitory effect of GS-E3D on iNOS and COX-2 protein 
expression in LPS-stimulated RAW264.7 cells. The cell was co-
treated with GS-E3D (25-200 µg/ml) and with or without LPS 
(1µg/ml) for 24 h. In western blot, each well was loaded with 25 
μg protein. % relative density of expressed iNOS and COX-2 bands 
in western blot was calculated by the density using the Chemi Doc 
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Fig. 3: Inhibitory effect of GS-E3D on TNF-α (A) and IL-6 (B) 
release in LPS-stimulated RAW264.7 cells. The cells were co-
treated with GS-E3D (50-200 µg/ml) and with or without LPS (1 
µg/ml) for 24 h. TNF-α and IL-6 release were decreased in LPS-
induced RAW 264.7 cells after treatment with GS-E3D in a dose-
dependent manner. Data are expressed as the mean±standard 
error of the mean (SEM) (n=5). ### p<0.001 compared to control 




Fig. 4: Inhibitory effect of GS-E3D against NF-ĸB activation in LPS-
stimulated RAW264.7 cells. Western blot analysis shows the 
inhibitory effect of GS-E3D on phosphorylation of IĸBα in cytosol 
and activation of NF-ĸB p65 in the nucleus. The cells were co-
treated with GS-E3D (50-200 µg/ml) and with or without LPS (1 
µg/ml) for 30 min. In western blot, each well was loaded with 25 
μg protein. % relative density of expressed bands in western blot 
was calculated by the density using the ChemiDoc XRS+with 
image lab software (Bio-Rad) 
At the dose of 100 μg/ml GS-E3D, NO production induced by LPS was 
strongly reduced to approximately basal levels compared with 
RAW264.7 cells unstimulated by LPS and treated with GS-E3D alone 
without LPS (fig. 1B). To further understand the inhibitory effects of 
GS-E3D on NO production, western blot analysis was performed to 
determine the expression of iNOS protein at 24 h after LPS stimulation. 
Under unstimulation of LPS, iNOS protein was not detectable. However, 
GS-E3D attenuated the iNOS expressions in LPS-stimulated RAW264.7 
cells in a concentration-dependent manner (fig. 2). 
This implies that GS-E3D inhibited NO production by suppressing iNOS 
expression in LPS-stimulated RAW264.7 cells. PGE2 is an inflammatory 
mediator which is produced from the conversion of arachidonic acid by 
cyclooxygenase. In a variety of inflammatory cells, including 
macrophages, COX-2 is induced by cytokines and other activators, such 
as LPS, resulting in the release of a large amount PGE2 at inflammatory 
sites [18]. Therefore, we evaluated the inhibitory effects of GS-E3D 
against PGE2 production in LPS-stimulated RAW264.7 macrophages. 
When macrophages were stimulated with LPS (1 μg/ml) without the GS-
E3D for 24 h, RAW264.7 macrophages produced PGE2 of 294 pg/ml in 
the culture medium. However, GS-E3D significantly inhibited the 
production of LPS-induced PGE2
As the previously mention, GS-E3D is pectin lyasetreated ginseng 
extract for enhancing ofginsenoside Rd. The contents of ginsenoside 
Rd in GS-E3D was higher 10 fold than that of ginseng extract (not 
treated with pectin lyase). Inhibitory effect of GS-E3D against NO and 
PGE2 production induced by LPS were significantly higher than those 
of ginseng extract (data was not shown). The difference of inhibitory 
effect against NO and PGE2 production between GS-E3D and ginseng 
extract maythink due to difference of ginsenoside Rd contents. 
 by 31% at 50 μg/ml, 45% at 100 μg/ml, 
and 68% at 200 μg/ml. RAW264.7 cells unstimulated by LPS and 
treated with GS-E3D alone without LPS secreted basal level of PGE2 
(fig. 1C). 
To determine whether inhibition of PGE2 production by GS-E3D was 
mediated by regulation of COX-2 expression, western blottinganalysis 
was performed. As shown in fig. 2, the expression of COX-2 protein 
was significantly increased in macrophages treated with LPS (1 μg/ml) 
alone compared to the unstimulated cells. However, GS-E3D 
significantly inhibited the production of LPS-induced COX-2 protein by 
10% at 100 μg/ml, and 37% at 200 μg/ml. This implies that GS-E3D 
potentially inhibited PGE2 production by suppressing COX-2 
expression in LPS-stimulated RAW264.7 cells. 
GS-E3D inhibits the release of TNF-α and IL-6 in LPS-stimulated RAW 
264.7 cells 
TNF-αand IL-6 are known to be pro-inflammatory cytokines, however 
inflammatory reaction is accelerated by these large amount of 
cytokines. Therefore, inflammation on RAW 264.7 cells by LPS 
stimulation with or without GS-E3D was studied. In order to 
investigate the effect of GS-E3D capable of inhibiting the medium was 
subject to investigate the production of IL-6 and TNF-α(fig 3). As a 
result, in the RAW 264.7 cells, LPS activated the production of TNF-α 
(82.5 pg/ml) and IL-6 (182.6 pg/ml) are significantly increased as 
compared to the control group (14.8 pg/ml TNF-α, 21.5 pg/ml IL-6). 
However, production of IL-6 and TNF-αactivated by LPS was 
significantly inhibited by GS-E3D in a concentration dependent 
manner. GS-E3D at the dose of 100 ug/mlinhibited the production of 
TNF-α(37.3 pg/ml) and IL-6 (96.0 pg/ml). However, at the dose of 200 
ug/ml, the inhibitory effect of GS-E3D on TNF-α(21.9 pg/ml) and IL-6 
(74.0 pg/ml) further supported its potential inhibitory activity. 
Inflammation promoting cytokines may play a role which regulates a 
variety of immune and inflammatory responses in the body. The 
macrophages stimulated by LPS of the bacterium produce a large 
amount of TNF-α, thereby sustained inflammatory responses by 
inducing the production of IL-1β and IL-6 [19]. TNF-α induced by LPS 
to promote the onset of inflammation reaction and its continued 
generation leads to chronic inflammation [20, 21]. IL-1β is a major 
inflammatory cytokine produced from macrophages and an important 
cytokine in the initiation and enhancement of the inflammatory 
response to bacterial infection [22]. IL-6 is considered as important 
inflammatory cytokine macrophage responsible for promoting gender 
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observed in the present study is to show that GS-E3Dclaim suppress 
the generation of IL-1β, IL-6, TNF-α induced by LPS stimulation, which 
is the initial step in the inflammatory response caused by LPS- 
stimulated and that the inhibition was successfully attained. 
Inhibitory effect of GS-E3D on activation of NF-κB and MAPK signaling 
pathway 
To evaluate whether the inhibitory effect of GS-E3D on iNOS 
expression is related to blocking NF-ĸB activation, we performed 
western blot for IĸB -α degradation and IĸB -α phosphorylation, since 
the phosphorylation and subsequent degradation of IĸB -α is an 
essential step in NF-ĸBactivation by various stimuli [24]. As shown in 
Fig. 4, LPS induced IĸB -α degradation at 30 min after LPS stimulation. 
However GS-E3D dose-dependently suppressed IĸB -α degradation 
induced by LPS. Moreover, to determine whether the effect of GS-E3D 
against IĸB -α degradation was mediated by blocking IĸB -α 
phosphorylation, we evaluated the inhibitory effect of GS-E3D against 
the phosphorylation of IĸB -α induced by LPS, and found that GS-E3D 
significantly reduced IĸB -α phosphorylation. From these results, it is 
thought that GS-E3D inhibits LPS-induced NF-ĸB activation. To further 
investigate whether the inhibition of GS-E3D on the expression of iNOS 
via blocking NF-kB activation is related to the modulation of MAPK 
pathway, we evaluated the effects of the GS-E3D on phosphorylation of 
p38, ERK1/2 and JNK in LPS-stimulated RAW264.7 cells by western 
blot (fig.5). Hyper-phosphorylation of p38, ERK1/2 and JNK was 
observed in RAW264. 7 cells treated with LPS alone compared to the 
untreated cells. However, GS-E3D suppressed LPS-induced 
phosphorylation of p38, ERK1/2 and JNK. These results suggest that 
GS-E3D blocks the phosphorylation of p38, ERK1/2 and JNK to 
suppress the inflammatory response in LPS-stimulated RAW264.7 
cells. Our data strongly indicate that GS-E3D possesses the anti-
inflammatory effect through suppressing NF-ĸB and MAPK signaling 
pathway. NF-κB pathway is regulated by protein signal transduction, 
such as phosphoric acid group MAPKs and Akt are involved in a 
variety of intracellular signal transduction [25-27]. In many studies, 
p38, JNK, MAPKs, such as the ERK reveals to play an important role in 
the activation of NF-κB from the LPS in macrophages [15, 28].  
Inhibitory effects of GS-E3D for activation of NF-κB induced by LPS 
stimulation in the results of the present study indicate that the process 
is related to the phosphorylation of MAPKs phosphate group signal 
transduction. In addition GS-E3D could inactivate the Nrf2 path to 
mediate the anti-inflammatory activity. These results, in LPS-
stimulated RAW264.7 cells, was demonstrated that inflammatory 
mediators such as NO, as well as the production of inflammatory 
cytokines and promoting gender expression is suppressed by the GS-
E3D. These inhibitory effects of GS-E3D has been shown to inactivate 
NF-κB by inhibiting the degradation pathway of IκB. GS-E3Dwas also 
found to affect also the upper MAPKs and Akt signaling pathway of NF-
κB activation. The anti-inflammatory effect and its mechanism studies 
of ginsenoside Rd, main compound of GS-E3D, remain to be further.
 
 
Fig. 5: Inhibitory effect of GS-E3D against MAPKs activation in LPS-stimulated RAW264.7 cells. Western blot analysis shows the inhibitory 
effect of GS-E3D on the phosphorylation of MAPKs such as p38MAPK, ERK1/2 and JNK. Cells were pre-treated with GS-E3D for 24 h and 
then 1 μg/ml of LPS was treated for 5 min. In western blot, each well was loaded with 25 μg protein. Relative % density of expressed 
bands in western blot was calculated by the density using the Chemi Doc XRS+with image lab software (Bio-Rad). 
 
CONCLUSION 
The present findings suggest that GS-E3D revealed anti-inflammatory 
effects by suppressing the NF-κB p65 and MAPKs signaling pathways 
and could be used as a functional food or a cosmetic materials.  
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